Patrick Hargutt

Founder at

Stanley Capital Partners LLP

40 year

9 connections

Finance

Health Technology

Consumer Services

Profile

Patrick Hargutt founded Stanley Capital Partners LLP in 2020, where he is working as Founding Partner from 2020.
Mr. Hargutt also currently works at Stanley Lab, Inc., as Founding Director from 2021, Laboratoire X.O, as Board Director from 2022, and Noden Pharma DAC, as Director from 2020.
Mr. Hargutt also formerly worked at Healthcare AI Acquisition Corp., as Chief Financial Officer & Director and Monarch Alternative Capital (Private Equity), as Vice President from 2018 to 2019.
Mr. Hargutt received his undergraduate degree in 2010 from Technische Universität München.

Patrick Hargutt active positions

Companies	Position	Start
Stanley Capital Partners LLP Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital invests in middle market companies located in the United States and Europe with EBITDA ranging from USD25 million - USD150 million with an enterprise values of USD250 million - USD2.5 billion. The firm targets companies operating in the fields of healthcare and technology. It provides financing for growth stage capital requirements.	Founder	01/01/2020
Noden Pharma DAC Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company	Director/Board Member	01/09/2020
Laboratoire X.O Laboratoire X.O Pharmaceuticals: MajorHealth Technology Manufactures and sells medical devices & medicines	Director/Board Member	01/09/2022
Stanley Lab, Inc. Stanley Lab, Inc. Drugstore ChainsRetail Trade Operates as a pharmacy	Director/Board Member	01/03/2021

All active positions of Patrick Hargutt

Former positions of Patrick Hargutt

Companies	Position	End
HEALTHCARE AI ACQUISITION CORP.	Director of Finance/CFO	12/06/2023
Monarch Alternative Capital (Private Equity) Monarch Alternative Capital (Private Equity) Investment ManagersFinance Monarch Alternative Capital seeks investment opportunities in companies located in the US. The firm targets companies operating in the fields of broad range of sectors. The firm provides financing in the form of debt of distressed and bankrupt companies.	Private Equity Investor	31/10/2019

See the detail of Patrick Hargutt's experience

Training of Patrick Hargutt

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Patrick Hargutt's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
Technische Universität München Technische Universität München Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Stanley Lab, Inc. Stanley Lab, Inc. Drugstore ChainsRetail Trade Operates as a pharmacy	Retail Trade
Laboratoire X.O Laboratoire X.O Pharmaceuticals: MajorHealth Technology Manufactures and sells medical devices & medicines	Health Technology
Monarch Alternative Capital (Private Equity) Monarch Alternative Capital (Private Equity) Investment ManagersFinance Monarch Alternative Capital seeks investment opportunities in companies located in the US. The firm targets companies operating in the fields of broad range of sectors. The firm provides financing in the form of debt of distressed and bankrupt companies.	Finance
Noden Pharma DAC Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company	Health Technology
Stanley Capital Partners LLP Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital invests in middle market companies located in the United States and Europe with EBITDA ranging from USD25 million - USD150 million with an enterprise values of USD250 million - USD2.5 billion. The firm targets companies operating in the fields of healthcare and technology. It provides financing for growth stage capital requirements.	Finance
Healthcare AI Acquisition Corp. Healthcare AI Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company	Finance